Sunscreen TEA Guidance In FDA 2015 Publishing Plan
This article was originally published in The Rose Sheet
Executive Summary
The majority of the guidances FDA’s drug center plans to publish in 2015 are for prescription drug development and manufacturing, while regulatory expectations for sunscreen ingredient submissions under the OTC drug monograph system account for most of the planned OTC-relevant guidances.